Investigation of Trends in the Research on Transferrin Receptor-Mediated Drug Delivery via a Bibliometric and Thematic Analysis
This study systematically reviews and characterizes the existing literature on transferrin/transferrin receptor-mediated drug delivery. Transferrin is an iron-binding protein. It can be used as a ligand to deliver various proteins, genes, ions, and drugs to the target site via transferrin receptors for therapeutic or diagnostic purposes via transferrin receptors. This study is based on a cross-sectional bibliometric analysis of 583 papers limited to the subject areas of pharmacology, toxicology, and pharmaceutics as extracted from the Scopus database in mid-September 2022. The data were analyzed, and we carried out a performance analysis and science mapping. There was a significant increase in research from 2018 onward. The countries that contributed the most were the USA and China, and most of the existing research was found to be from single-country publications. Research studies on transferrin/transferrin receptor-mediated drug delivery focus on drug delivery across the blood-brain barrier in the form of nanoparticles. The thematic analysis revealed four themes: transferrin/transferrin receptor-mediated drug delivery to the brain, cancer cells, gene therapy, nanoparticles, and liposomes as drug delivery systems. This study is relevant to academics, practitioners, and decision makers interested in targeted and site-specific drug delivery.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:14 |
---|---|
Enthalten in: |
Pharmaceutics - 14(2022), 12 vom: 23. Nov. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Kaur, Tarnjot [VerfasserIn] |
---|
Links: |
---|
Themen: |
Bibliometric analysis |
---|
Anmerkungen: |
Date Revised 27.12.2022 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/pharmaceutics14122574 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM350705895 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM350705895 | ||
003 | DE-627 | ||
005 | 20231226045609.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/pharmaceutics14122574 |2 doi | |
028 | 5 | 2 | |a pubmed24n1168.xml |
035 | |a (DE-627)NLM350705895 | ||
035 | |a (NLM)36559067 | ||
035 | |a (PII)2574 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Kaur, Tarnjot |e verfasserin |4 aut | |
245 | 1 | 0 | |a Investigation of Trends in the Research on Transferrin Receptor-Mediated Drug Delivery via a Bibliometric and Thematic Analysis |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 27.12.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a This study systematically reviews and characterizes the existing literature on transferrin/transferrin receptor-mediated drug delivery. Transferrin is an iron-binding protein. It can be used as a ligand to deliver various proteins, genes, ions, and drugs to the target site via transferrin receptors for therapeutic or diagnostic purposes via transferrin receptors. This study is based on a cross-sectional bibliometric analysis of 583 papers limited to the subject areas of pharmacology, toxicology, and pharmaceutics as extracted from the Scopus database in mid-September 2022. The data were analyzed, and we carried out a performance analysis and science mapping. There was a significant increase in research from 2018 onward. The countries that contributed the most were the USA and China, and most of the existing research was found to be from single-country publications. Research studies on transferrin/transferrin receptor-mediated drug delivery focus on drug delivery across the blood-brain barrier in the form of nanoparticles. The thematic analysis revealed four themes: transferrin/transferrin receptor-mediated drug delivery to the brain, cancer cells, gene therapy, nanoparticles, and liposomes as drug delivery systems. This study is relevant to academics, practitioners, and decision makers interested in targeted and site-specific drug delivery | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a bibliometric analysis | |
650 | 4 | |a drug delivery | |
650 | 4 | |a performance analysis | |
650 | 4 | |a scientific mapping | |
650 | 4 | |a thematic analysis | |
650 | 4 | |a transferrin receptor | |
700 | 1 | |a Upadhyay, Jyoti |e verfasserin |4 aut | |
700 | 1 | |a Pukale, Sudeep |e verfasserin |4 aut | |
700 | 1 | |a Mathur, Ashish |e verfasserin |4 aut | |
700 | 1 | |a Ansari, Mohd Nazam |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Pharmaceutics |d 2010 |g 14(2022), 12 vom: 23. Nov. |w (DE-627)NLM204303303 |x 1999-4923 |7 nnns |
773 | 1 | 8 | |g volume:14 |g year:2022 |g number:12 |g day:23 |g month:11 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/pharmaceutics14122574 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 14 |j 2022 |e 12 |b 23 |c 11 |